In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions
Authors
Keywords
-
Journal
mAbs
Volume 9, Issue 3, Pages 476-489
Publisher
Informa UK Limited
Online
2017-01-27
DOI
10.1080/19420862.2017.1285479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
- (2016) James C. Geoghegan et al. mAbs
- Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
- (2016) Dheeraj S. Tomar et al. mAbs
- Critical Examination of the Colloidal Particle Model of Globular Proteins
- (2015) Prasad S. Sarangapani et al. BIOPHYSICAL JOURNAL
- Computational tool for the early screening of monoclonal antibodies for their viscosities
- (2015) Neeraj J Agrawal et al. mAbs
- Antibodies to watch in 2016
- (2015) Janice M. Reichert mAbs
- Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobicversuselectrostatic inter-molecular interactions
- (2015) Pilarin Nichols et al. mAbs
- Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
- (2015) Giovanna Scapin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
- (2015) Giovanna Scapin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Protein aggregation and its impact on product quality
- (2014) Christopher J Roberts CURRENT OPINION IN BIOTECHNOLOGY
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Highly Viscous Antibody Solutions Are a Consequence of Network Formation Caused by Domain–Domain Electrostatic Complementarities: Insights from Coarse-Grained Simulations
- (2014) Patrick M. Buck et al. MOLECULAR PHARMACEUTICS
- Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular Properties
- (2014) Li Li et al. PHARMACEUTICAL RESEARCH
- Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry
- (2014) Jianxin Guo et al. PHARMACEUTICAL RESEARCH
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
- (2014) Vikas K. Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Which are the antibodies to watch in 2013?
- (2013) Janice M. Reichert mAbs
- IgBLAST: an immunoglobulin variable domain sequence analysis tool
- (2013) Jian Ye et al. NUCLEIC ACIDS RESEARCH
- Impact of deglycosylation and thermal stress on conformational stability of a full length murine igG2a monoclonal antibody: Observations from molecular dynamics simulations
- (2013) Xiaoling Wang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Weak Interactions Govern the Viscosity of Concentrated Antibody Solutions: High-Throughput Analysis Using the Diffusion Interaction Parameter
- (2012) Brian D. Connolly et al. BIOPHYSICAL JOURNAL
- Disulfide bond structures of IgG molecules
- (2012) Hongcheng Liu et al. mAbs
- Disulfide Scrambling in IgG2 Monoclonal Antibodies: Insights from Molecular Dynamics Simulations
- (2011) Xiaoling Wang et al. PHARMACEUTICAL RESEARCH
- Calibrative approaches to protein solubility modeling of a mutant series using physicochemical descriptors
- (2010) William F. Long et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
- (2010) Frank R. Brennan et al. mAbs
- Exploring the sequence determinants of amyloid structure using position-specific scoring matrices
- (2010) Sebastian Maurer-Stroh et al. NATURE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started